Supplemental bifid triple viable capsule treatment improves inflammatory response and T cell frequency in ulcerative colitis patients

BACKGROUND: Ulcerative colitis is a common non-specific chronic disease. Supplementing probiotics has become an important method for the treatment of ulcerative colitis. This study aimed to explore the effect of supplementing bifid triple viable capsules on background mesalazine plus somatostatin on...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Shuying, Yin, Yan, Xiao, Dan, Zou, Yong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8335873/
https://www.ncbi.nlm.nih.gov/pubmed/34348654
http://dx.doi.org/10.1186/s12876-021-01887-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8335873/
https://www.ncbi.nlm.nih.gov/pubmed/34348654
http://dx.doi.org/10.1186/s12876-021-01887-2

Ejemplares similares